Editor’s Note: Looking forward

The Rare Diseases Report: Cancers supplement looks to the future from trial design to treatment for some of the most underserved diseases and patient populations.

In this special report we bring you the latest information on new and ongoing developments in the treatment of a number of cancer types through interviews with leaders in the field. And in this unique time of COVID-19 disease, we provide an update on the effects of the pandemic on immune system issues in this highly vulnerable population of cancer patients. In addition, we feature some of the critical issues of dealing with racial, ethnic, sex, and gender disparities among others in these unique populations. We hope you enjoy the issue.

– Mark S. Lesney, PhD
   Editor